Skip to main content
KURA
NASDAQ Life Sciences

Kura CEO Troy Wilson Buys 200,000 Shares for $1.5 Million Open-Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.15
Mkt Cap
$651.42M
52W Low
$6.75
52W High
$13.9
52W Position info
5.9% above low
Off High info
49% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

KURA is trading near its 52-week low of $6.75 (5.9% above the low).

Summary

Kura CEO Troy Wilson bought 200,000 shares for about $1.5 million in open-market trades on November 13 and 16, his second large purchase since August.


Key Events · Ownership and Investor Activity · KURA

  • CEO Buys 200,000 Shares

    Troy Wilson purchased 200,000 shares in two open-market trades for a total of $1,504,765.01.

  • Weighted-Average Prices

    The trades comprised 98,881 shares at $7.63 on 2026-11-13 and 101,119 shares at $7.42 on 2026-11-16, both weighted averages across multiple trades.

  • Holdings Rise to 635,456

    Direct ownership after the purchases is 635,456 shares, plus 479,194 held by the One Fish Two Fish Revocable Trust and 300,000 by the Lorax Charitable Remainder Unitrust.

  • Second Large Buy Since August

    Follows a 100,000-share, $1.24 million open-market purchase reported 2026-08-24.


Analysis · KURA · Life Sciences

Why it matters: the CEO put $1.5 million of his own money into the stock across two open-market trades, lifting his direct stake to 635,456 shares. This follows a $1.24 million purchase in August, so it reads as repeated conviction buying rather than a one-off, and it stands out against a 90-day insider picture that otherwise leans toward selling. The buys were executed at weighted-average prices of $7.63 and $7.42, bracketing today's $7.15 quote.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, KURA was trading at $7.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $651.4M. The 52-week trading range was $6.75 to $13.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KURA - Latest Insights

KURA
Nov 10, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.29
Real-time Price: $7.40 info
Change: +$0.110 (+2%) info
Market Cap: $651.42M info
KURA
Nov 10, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.20
Real-time Price: $7.40 info
Change: +$0.200 (+3%) info
Market Cap: $651.42M info
KURA
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.45
Real-time Price: $7.40 info
Change: -$0.050 (-0.67%) info
Market Cap: $651.42M info
KURA
Nov 10, 2026, 4:02 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.45
Real-time Price: $7.40 info
Change: -$0.050 (-0.67%) info
Market Cap: $651.42M info
KURA
Sep 29, 2026, 5:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.70
Real-time Price: $7.40 info
Change: -$3.30 (-31%) info
Market Cap: $651.42M info